ProPhase Labs, Inc. (PRPH): Price and Financial Metrics

ProPhase Labs, Inc. (PRPH): $8.48

-0.04 (-0.47%)

POWR Rating

Component Grades













Add PRPH to Watchlist
Sign Up

Industry: Biotech



in industry

PRPH Stock Summary

  • Over the past twelve months, PRPH has reported earnings growth of 155.82%, putting it ahead of 87.12% of US stocks in our set.
  • Revenue growth over the past 12 months for ProPhase Labs Inc comes in at 212.58%, a number that bests 96.24% of the US stocks we're tracking.
  • ProPhase Labs Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -32.31%, greater than the shareholder yield of only 12.24% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ProPhase Labs Inc, a group of peers worth examining would be SEED, RMAX, CIDM, HURN, and MMYT.
  • PRPH's SEC filings can be seen here. And to visit ProPhase Labs Inc's official web site, go to

PRPH Valuation Summary

  • PRPH's price/earnings ratio is -47.1; this is 229.04% lower than that of the median Healthcare stock.
  • PRPH's price/sales ratio has moved up 2 over the prior 243 months.
  • PRPH's price/sales ratio has moved up 2 over the prior 243 months.

Below are key valuation metrics over time for PRPH.

Stock Date P/S P/B P/E EV/EBIT
PRPH 2021-08-31 2.4 1.7 -47.1 -91.8
PRPH 2021-08-30 2.5 1.8 -49.1 -95.8
PRPH 2021-08-27 2.5 1.7 -47.9 -93.5
PRPH 2021-08-26 2.4 1.7 -47.3 -92.2
PRPH 2021-08-25 2.4 1.7 -47.3 -92.2
PRPH 2021-08-24 2.5 1.8 -48.5 -94.7

PRPH Growth Metrics

    Its 4 year net income to common stockholders growth rate is now at 17.27%.
  • Its 2 year cash and equivalents growth rate is now at -79.42%.
  • Its 3 year revenue growth rate is now at -40.16%.
PRPH's revenue has moved up $25,922,000 over the prior 33 months.

The table below shows PRPH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 39.048 -15.74 -5.294
2021-06-30 33.416 -10.699 -1.724
2021-03-31 27.897 -10.769 -0.259
2020-12-31 14.514 -2.592 -2.125
2020-09-30 12.492 3.748 -1.614
2020-06-30 11.418 3.34 -1.634

PRPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PRPH has a Quality Grade of F, ranking ahead of 3.86% of graded US stocks.
  • PRPH's asset turnover comes in at 0.618 -- ranking 52nd of 680 Pharmaceutical Products stocks.
  • NBIX, CEMI, and ENDP are the stocks whose asset turnover ratios are most correlated with PRPH.

The table below shows PRPH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.618 0.488 -0.022
2021-03-31 0.733 0.470 0.011
2020-12-31 0.738 0.317 -0.105
2020-09-30 0.839 0.299 -0.131
2020-06-30 0.876 0.309 -0.152
2020-03-31 0.680 0.266 -0.244

PRPH Price Target

For more insight on analysts targets of PRPH, see our PRPH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $14.50 Average Broker Recommendation 1.75 (Moderate Buy)

PRPH Stock Price Chart Interactive Chart >

Price chart for PRPH

PRPH Price/Volume Stats

Current price $8.48 52-week high $9.28
Prev. close $8.52 52-week low $4.44
Day low $8.35 Volume 92,600
Day high $8.89 Avg. volume 28,393
50-day MA $7.50 Dividend yield N/A
200-day MA $6.56 Market Cap 131.32M

ProPhase Labs, Inc. (PRPH) Company Bio

ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The Company's products reduce the duration and severity of common cold symptoms. ProPhase also manufactures nutrition and weight management products.

PRPH Latest News Stream

Event/Time News Detail
Loading, please wait...

PRPH Latest Social Stream

Loading social stream, please wait...

View Full PRPH Social Stream

Latest PRPH News From Around the Web

Below are the latest news stories about ProPhase Labs Inc that investors may wish to consider to help them evaluate PRPH as an investment opportunity.

ProPhase Labs declares $0.30 dividend

ProPhase Labs (NASDAQ:PRPH) declares $0.30/share special dividend.Payable March 10; for shareholders of record March 1; ex-div Feb.

Seeking Alpha | February 16, 2022

ProPhase Labs Announces Special Cash Dividend

Anticipates Record Q4 2021 and Q1 2022 Revenues and Profits Garden City, NY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, announced today that its Board of Directors has declared a special cash dividend in the amount of $0.30 per share on its common stock, payable on March 10, 2022 to stockholders of record as of March 1, 2022. “Given our strong projected financial performance in net income and EBITDA for the fourth quarter of

Yahoo | February 16, 2022

Is ProPhase Labs (NASDAQ:PRPH) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Yahoo | February 8, 2022

ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference

GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the MicroCap Rodeo Winter Wonderland Best Ideas Conference, which is being held virtually from February 8 – 11, 2022. Mr. Karkus will deliver his corporate presentation on Wednesday, February 9, 2022 at 12:00 PM ET. Event Webcast URL: Mr. Karkus will be

Yahoo | February 3, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th \- 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time.

Yahoo | January 28, 2022

Read More 'PRPH' Stories Here

PRPH Price Returns

1-mo 18.77%
3-mo 28.48%
6-mo 28.68%
1-year 76.67%
3-year 182.18%
5-year 348.68%
YTD 18.27%
2021 -21.90%
2020 365.99%
2019 -37.46%
2018 45.16%
2017 8.50%

Continue Researching PRPH

Here are a few links from around the web to help you further your research on ProPhase Labs Inc's stock as an investment opportunity:

ProPhase Labs Inc (PRPH) Stock Price | Nasdaq
ProPhase Labs Inc (PRPH) Stock Quote, History and News - Yahoo Finance
ProPhase Labs Inc (PRPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7277 seconds.